TBVAC2020-332793 Systems biology analysis to define biosignatures of protection to latent TB

Summary

Systems biology analysis to define biosignatures of protection to latent TB using TB exposed but persistently TST negative subjects (combined metabolomics, RNA-seq) (M36)

More information & hyperlinks

Web resources:

https://www.ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5b8ce41e6&appId=PPGMS

Associated projects

TBVAC2020 - TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development

Organisations

Not specified